|
|
| |
| Strategic Orientation and Its Relation to the Development of the Pharmaceutical Industry for Companies Operating in the Field of Medicine in Palestine |
Samer M. Arqawi, Amal A. Al hila, Samy S. Abu-Naser, Mazen J. Al Shobaki
|
Abstract:
This study presented the strategic orientation and its relation to the development of the pharmaceutical industry for companies operating in the field of medicine in the West Bank - Palestine. The study population consists of all the workers in the companies operating in the field of medicine in Palestine, which are (5) producing companies in the West Bank - Palestine only for pharmaceuticals used by these companies, which are (296) employees, and used a simple random sample to choose the sample and size of the study was (87) employees of the study community, and to achieve the objectives of the study (87) questionnaires were distributed. The descriptive analytical approach was used, and SPSS was used.
The most important results which the study reached: The pharmaceutical industry in Palestine is strategically oriented, with an average of (3.7), i.e. with verification rate of 67.5% indicating that companies have an average strategic direction. The research and development activities of these companies have an average of (5.8), i.e. (85%). And that R & D has a strategic role to achieve long-term high quality. While the use of pharmaceutical techniques in the field of product planning and development reached an average of (3.18), with verification rate of (58%). While we find the field of pharmaceutical products Design using computers are the most powerful of these components with verification rate of (63%), followed by the company's continuous use of the latest technology in the field of product planning with verification rate of (60%). Finally, the company is keen to use the latest technology in the pharmaceutical industry with verification rate of (51%).
The study suggested several recommendations, the most important of which is to work on activating the various strategic policy areas of pharmaceutical companies in Palestine. And to activate weaknesses in the strategic direction of companies operating in the field of medicine in Palestine, through the development of short-, medium- and long-term plans capable of strengthening the weaknesses that are in addition to the use of pharmaceutical techniques in the field of product planning and development in order to be able to compete at the local and global level.
|
|
|
| | |